Secondary mitral and tricuspid regurgitation accompanying left ventricular systolic dysfunction: is it important, and how is it treated?
Trichon
Benjamin H
BH
O'Connor
Christopher M
CM
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008943:Mitral Valve / Q000601:surgery; D008944:Mitral Valve Insufficiency / Q000188:drug therapy / Q000503:physiopathology* / Q000601:surgery; D013599:Systole / Q000187:drug effects / Q000502:physiology*; D014261:Tricuspid Valve / Q000601:surgery; D014262:Tricuspid Valve Insufficiency / Q000188:drug therapy / Q000503:physiopathology* / Q000601:surgery; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy / Q000503:physiopathology* / Q000601:surgery; D020257:Ventricular Remodeling / Q000187:drug effects / Q000502:physiology*
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors